ChemPartner, a CRO based in Shanghai, has reportedly accepted a capital investment of more than $30 million in return for a minority stake in the company. The investor is the American private equity firm TPG, a high-profile investment company that made its name and a considerable fortune in turnaround situations and leveraged buyouts. More details...

Stock Symbols: (NYSE: LLY) (NYSE: WX)